| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eccd894c99fea2d1c0c8735872bb2309 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01D9-0054 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01D9-00 |
| filingDate |
2018-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dde7ba88d091020677ca120e97e07e44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0be4880b193ceae27e76d1b6345d36aa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e5150312ff7e016f02ec6e5d955b0a9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db44375af4b38559303e8faebbf45ea5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad9b183b11b1802f72e6dde28e3f3d3e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc85f9d1a5ada8b810b5d296fa5e4f33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c1fb9038a55048f914da59beb2d05b4 |
| publicationDate |
2020-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2020123144-A1 |
| titleOfInvention |
Solid form of (S)-[2-chloro-4-fluoro-5-(7-morpholin-4-yl-quinazolin-4-yl)phenyl]-(6-methoxy-pyridazin-3-yl)-methanol |
| abstract |
An anhydrous disordered crystalline (S)-[2-chloro-4-fluoro-5-(7-morpholin-4-yl-quinazolin-4-yl)-phenyl]-(6-methoxy-pyridazin-3-yl)-methanol can be used in pharmaceutical compositions. |
| priorityDate |
2017-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |